Research Guide
How to read biotech clinical endpoints
Clinical endpoints define what a trial is trying to prove. For investors and industry readers, the key question is not only whether a p-value is positive, but whether the endpoint reflects meaningful patient benefit, regulatory relevance, and commercial differentiation.
What to check first
Start with the evidence that can change value: clinical relevance, regulatory path, competitive context, financing needs, and whether the company can reach the next milestone.
How Drugnews uses this guide
We apply these frameworks when writing company research, paid analysis, and client-facing content so that readers can follow the logic behind each judgment.